000028.SZ
国药一致
SZSE · Healthcare · F 批发零售 · CN
CNY 19.59
+0.62%Year over year
Reported trailing growth
- Revenue
- -0.9%
- EBITDA
- —
- EBIT
- +209.5%
- EPS
- +89.4%
- Free cash flow
- -81.2%
- Operating cash flow
- -75.1%
Forward estimates
Based on analyst estimates
- Revenue
- +4.9%
- EBITDA
- -4.9%
- EPS
- -4.1%
Three-year CAGR
- Revenue
- -0.0%
- EBITDA
- +2.5%
- EBIT
- -13.1%
- Net income
- -8.6%
- EPS
- -8.6%
- Free cash flow
- -14.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026